Abstract
Viral nanoparticles (VNPs) are versatile systems for the delivery of vaccines and other therapeutic agents for the treatment of diseases such as cancer or those related to the immune-system, degenerative diseases, and infections caused due to agents like viruses, bacteria, and fungi. Additionally, the VNPs are also used in molecular diagnostics, in the development of films and arrays for applications in electronics and tissue engineering, the design of data storage devices, and devices for tissue-specific imaging and therapy. The ability of viruses and bacteriophages to invade and infect different kinds of host cells empower them as suitable nanocarriers wherein they are able to cross biological barriers that obstruct drug delivery. VNPs are generally produced by genetic or chemical engineering by inserting heterologous sequences or ligands of interest into surface-exposed loops of the capsid proteinĀ (CPs). The CPs of viruses are the protein-building blocks that can self-assemble and are inherently biodegradable. The capsids that are generated artificially using the modified version of the CPs are known as virus-like particles (VLPs) to which ligands, peptides, and other agents are conjugated to generate VNPs. VNPs can self-assemble either as discrete structures or may organize themselves into films and arrays. Specific formulations of VNPs loaded with biomolecules such as antibodies and aptamers or biomimetics significantly improve efficacy and function by modulating tissue localization. The potential of VNP-based vaccine therapy is yet to be fully explored and it is expected that it will continue to evolve with more effective design and applicability for the treatment of various diseases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abraham A et al (2016) Intracellular delivery of antibodies by chimeric Sesbania mosaic virus (SeMV) virus like particles. Nat Publ Group 6:21803. https://doi.org/10.1038/srep21803
Acosta-Ramirez E et al (2008) Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus. Immunology 124:186ā197
Agnandji S et al (2012) A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. New Engl J Med Orig 367:2284ā2295. https://doi.org/10.1056/NEJMoa1208394
Alemzadeh E, Izadpanah K, Ahmadi F (2017) Generation of recombinant protein shells of Johnson grass chlorotic stripe mosaic virus in tobacco plants and their use as drug carrier. J Virol Methods 248:148ā153
Aljabali AAA, Lomonossoff GP, Evans DJ (2011) CPMV-polyelectrolyte-Templated gold nanoparticles. Biomacromolecules 12(7):2723ā2728
Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818ā1822. https://doi.org/10.1126/science.1095833
Allen M et al (2005) Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med 54(4):807ā812
AmbĆ¼hl P et al (2007) A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. J Hypertens 25(1):63ā72
Andrianova E et al (2011) Foot and mouth disease virus polyepitope protein produced in bacteria and plants induces protective immunity in Guinea pigs. Biochemistry 76:339ā346
Angel M, Lim G (2007) Transgenic plants in therapeutically valuable protein production. Trans Plant J 1(2):256ā266
AR v Z, II H (2016) Purification of virus-like particles (VLPs) from plants. Method Mol Biol 1404:569ā579
Batista FD, Harwood NE (2009) The who, how and where of antigen presentation to B cells. Nat Rev Immunol 9:15ā27
Bell J, McFadden G (2015) Viruses for tumor therapy. Cell Host Microbe 15(3):260ā265. https://doi.org/10.1016/j.chom.2014.01.002.Viruses.
Berman H et al (2000) The protein data Bank. Nucleic Acids Res 28(1):235ā242. https://doi.org/10.1093/nar/28.1.235
Bessa J etĀ al (2008) Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design. Eur J Immunol 38(1):114ā126
Biabanikhankahdani R et al (2018) A dual bioconjugated virus-like nanoparticle as a drug delivery system and comparison with a pH-responsive delivery system. Nano 8:236. https://doi.org/10.3390/nano8040236
Birnbaum F, Nassal M (1990) Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol 64(7):3319ā3330
Bludau H et al (2017) POxylation as an alternative stealth coating for biomedical applications Herdis. Eur J Immunol 88:679ā688. https://doi.org/10.1016/j.eurpolymj.2016.10.041.POxylation.
Brennan F et al (1999a) Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine 17(15ā16):1846ā1857
Brennan FR et al (1999b) Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus. Microbiology 145:211ā220
Bruckman M et al (2008) Surface modification of tobacco mosaic virus with āclickā chemistry. Chembiochem 9(4):519ā523
Brumfield S et al (2004) Heterologous expression of the modified coat protein of cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function. J Gen Virol 85:1049ā1053. https://doi.org/10.1099/vir.0.19688-0
Brune KD, Howarth M, Howarth M (2018) New routes and opportunities for modular construction of particulate vaccines: stick, click, and glue. Front Immunol 9:1050ā1074. https://doi.org/10.3389/fimmu.2018.01432
Brunel FM et al (2014) A hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. Nano Lett 10(3):1093ā1097. https://doi.org/10.1021/nl1002526.A.
Caldeira JC, Peabody DS (2007) Stability and assembly in vitro of bacteriophage PP7 virus-like particles. J Nanobiotechnol 10:1ā10. https://doi.org/10.1186/1477-3155-5-10.
Cao J etĀ al (2015) Development of Abamectin loaded plant virus nanoparticles for efficacious plant parasitic nematode control. ACS Appl Mater Interfaces 7(18):9546ā9553
Champion JA, Mitragotri S (2010) Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 26(1):244ā249. https://doi.org/10.1007/s11095-008-9626-z.
Chan J, Berek J (2007) Impact of the human papilloma vaccine on cervical cancer. J Clin Oncol 25:2975ā2982
Chattopadhyay S et al (2017) Nanoparticle vaccines adopting virus-like features for enhanced immune potentiation. Nano 1(3):244ā260
Chen Q, Lai H (2013) Plant-derived virus-like particles as vaccines. Hum Vaccin Immunother 9(1):26ā49
Chen TH et al (2012) Induction of protective immunity in chickens immunized with plant-made chimeric bamboo mosaic virus particles expressing very virulent infectious bursal disease virus antigen. Virus Res 166:109ā115
Chen Z et al (2017) Cryo-EM structure of the bacteriophage T4 isometric head at 3. 3-Ć resolution and its relevance to the assembly of icosahedral viruses. Proc Natl Acad Sci:E8184āE8193. https://doi.org/10.1073/pnas.1708483114
Choi K (2013) Review article a virus-like particle vaccine against infectious bursal disease virus: potential uses and applications. Br J Virol 3(1):1ā5
Crick FH, Watson JD (1956) Structure of small viruses. Nature 177:473ā475
Czapar AE et al (2016) Tobacco mosaic virus delivery of Phenanthriplatin for Cancer therapy. ACS Nano 10(4):4119ā4126. https://doi.org/10.1021/acsnano.5b07360.Tobacco.
Dalsgaard K et al (1997) Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol 15:248ā252
Denis J etĀ al (2008) Development of a universal influenza a vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine 26:3395ā3403
DĆaz-Valle A et al (2015) Highly efficient strategy for the heterologous expression and purification of soluble cowpea chlorotic mottle virus capsid protein and in vitro pH-dependent assembly of virus-like particles. J Virol Methods 225:23ā29
Dirksen A, Dawson PE (2008) Rapid Oxime and Hydrazone ligations with aromatic aldehydes for biomolecular labeling. Bioconjug Chem 19(12):2543ā2548
Douglas T, Young M (1998) Hostāguest encapsulation of materials by assembled virus protein cages. Nature 393:152ā155
Douglas T et al (2002) Protein engineering of a viral cage for constrained nanomaterials synthesis. Adv Mater 14(6):415ā418
El-attar L et al (2009) Comparison of the efficacy of rotavirus VLP vaccines to a live homologous rotavirus vaccine in a pig model of rotavirus disease. Vaccine 27:3201ā3208. https://doi.org/10.1016/j.vaccine.2009.03.043
Erovska NOC et al (2012) Transient expression of human papillomavirus type 16 L2 epitope fused to N- and C-terminus of coat protein of potato virus X in plants. J Biosci 37(January):125ā133. https://doi.org/10.1007/s12038-011-9177-z.
Fakruddin M, Hossain Z, Afroz H (2012) Prospects and applications of nanobiotechnology: a medical perspective. J Nanobiotechnol 10(1):1ā8
Fischer R et al (1999) Towards molecular farming in the future: moving from diagnostic protein and antibody production in microbes to plants. Biotechnol Appl Biochem 30(2):101ā108
Freivalds J etĀ al (2006) Assembly of bacteriophage QĪ² virus-like particles in yeast Saccharomyces cerevisiae and Pichia pastoris. J Biotechnol 123(3):297ā303
Gardner T, Elzey B, Hahn N (2012) Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer. Hum Vaccin Immunother 8(4):534ā539
Geiger F et al (2013) TMV nanorods with programmed longitudinal domains of differently addressable coat proteins. Nanoscale 5(9):3808ā3816
Giannini C et al (1995) Structural analysis of ZnS/GaAs heterostructures grown by hydrogen transport vapor-phase epitaxy. J Appl Phys 77:2429
Gonza L et al (2012) Chimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7Ā ā dependent tumors. PLoS One 7(12):1ā12. https://doi.org/10.1371/journal.pone.0052976
Gonzalez MJ et al (2009) Interaction of cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo. PLoS One 4:E7981
Grgacic E, Anderson D (2006) Virus-like particles: passport to immune recognition. Methods 40(1):60ā65
Hanafi LA et al (2010) Two distinct chimeric potexviruses share antigenic cross-presentation properties of mhc class I epitopes. Vaccine 28:5617ā5626
Hassani-Mehraban A et al (2015) Feasibility of cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations. BMC Biotechnol 15:80
Hefferon KL (2018) Repurposing plant virus nanoparticles. Vaccine 6:11. https://doi.org/10.3390/vaccines6010011
Hendin H et al (2017) Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro. Vaccine 35(19):2592ā2599
Honarbakhsh S et al (2013) Polymeric systems incorporating plant viral nanoparticles for tailored release of therapeutics. Adv Healthc Mater 2(7):1001ā1007
Hong V et al (2012) Analysis and optimization of copper-catalyzed Azideāalkyne cycloaddition for bioconjugation. Angew Chem Int Ed 48(52):9879ā9883. https://doi.org/10.1002/anie.200905087.Analysis.
Hovlid ML et al (2014) Terms of use Encapsidated atom-transfer radical polymerization in Q Ī² virus-like nanoparticles. ACS Nano 8(8):8003ā8014
Hwang D, Roberts I, Wilson T (1994) Expression of tobacco mosaic virus coat protein and assembly of pseudovirus particles in Escherichia coli. Proc Natl Acad Sci 91(19):9067ā9071
Jeevanandam J etĀ al (2018) Review on nanoparticles and nanostructured materials : history, sources, toxicity and regulations. Beilstein J Nanotechnol 9:1050ā1074. https://doi.org/10.3762/bjnano.9.98
Jennings G, Bachmann M (2009) Immunodrugs: therapeutic VLP-based vaccines for chronic diseases. Annu Rev Pharmacol Toxicol 49:303ā326
Jiang L et al (2006) A modified tmv-based vector facilitates the expression of longer foreign epitopes in tobacco. Vaccine 24:109ā115
Jobsri J etĀ al (2015) Plant virus particles carrying tumour antigen activate TLR7 and induce high levels of protective antibody. PLoS One 10:e0118096
Joelson T et al (1997) Presentation of a foreign peptide on the surface of tomato bushy stunt virus. J Gen Virol 78:1213ā1217
Jordan PC et al (2016) Self-assembling biomolecular catalysts for hydrogen production. Nat Chem 8:179ā185
Kaiser CR et al (2007) Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo.ā, Journal of. Nanomedicine 2:715ā733
Kaltgrad E et al (2007) Anti-carbohydrate antibodies elicited by polyvalent display on a viral scaffold. Chembiochem 8:1455ā1462
Kemnade JO et al (2014) Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivo. Vaccine 32:4228ā4233
Kessans SA et al (2013) Biological and biochemical characterization of HIV-1 gag/dgp41 virus-like particles expressed in Nicotiana benthamiana. Plant Biotechnol J 11(6):681ā690
Khor IW et al (2002) Novel strategy for inhibiting viral entry by use of a cellular receptor-plant virus chimera. J Virol 76:4412ā4419
Kim H, Kim H (2017) Yeast as an expression system for producing virus-like particles: what factors do we need to consider? Lett Appl Microbiol 64(2):111ā123
Knez M et al (2003) Biotemplate synthesis of 3-nm nickel and cobalt nanowires. Nano Lett 3(8):1079ā1082
Koudelka KJ et al (2016) Virus-based nanoparticles as versatile Nanomachines. Annual Review of Virology 2(1):379ā401. https://doi.org/10.1146/annurev-virology-100114-055141.Virus-Based.
Krammer F et al (2015) Europe PMC Funders Group Trichoplusia ni cells (High Five ā¢) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines. 45(3):226ā234. https://doi.org/10.1007/s12033-010-9268-3.Trichoplusia.
Kratzer B et al (2018) Running title: shielding of allergens inside virus-like nanoparticles. Exp Allergy Immunol. https://doi.org/10.1111/all.13573
Kueh CL et al (2016) Virus-like particle of Macrobrachium rosenbergii nodavirus produced in Spodoptera frugiperda (Sf9) cells is distinctive from that produced in Escherichia coli. Biotechnol Prog 33(2):549ā557
Lacasse P et al (2008) Novel plant virus-based vaccine cell, induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic maturation. J Virol 82:785ā794
Langeveld JP et al (2001) Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus. Vaccine 19:3661ā3670
Lebel ME et al (2014) Nanoparticle adjuvant sensing by TLR7 enhances CD8+ T cell-mediated protection from listeria monocytogenes infection. Immunology 192:1071ā1078
Lebel M-ĆØ et al (2015) Plant viruses as nanoparticle-based vaccines and adjuvants. Vaccine 3:620ā637. https://doi.org/10.3390/vaccines3030620
Leclerc D et al (2007) Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells. J Virol 81:1319ā1326
Lee KL, Steinmetz N (2017) Virus-based nanoparticles as platform technologies for modern vaccines. Wiley Interdiscip Rev Nanomed Nanobiotechnol 8(4):554ā578. https://doi.org/10.1002/wnan.1383.Virus-based
Lee C et al (2009) Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli. 7:1ā7. https://doi.org/10.1186/1423-0127-16-69.
Lee KL et al (2017) Genetic engineering and chemical conjugation of potato virus X. Methods Mol Biol 1108:3ā21. https://doi.org/10.1007/978-1-62703-751-8.
Lee Y et al (2018) Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross- protection against heterosubtypic influenza viruses. PLoS One 13(1):e0190868
Lemere CA (2013) MER5101, a novel AĪ²1-15:DT conjugate vaccine, generates a robust anti-AĪ² antibody response and attenuates AĪ² pathology and cognitive deficits in APPswe/PS1ĪE9 transgenic mice. J Neurosci 33(16):7027ā7037. https://doi.org/10.1523/JNEUROSCI.5924-12.2013.MER5101
Lewis JD et al (2006) Viral nanoparticles as tools for intravital vascular imaging. Nat Med 12(3):354ā360. https://doi.org/10.1038/nm1368.Viral.
Lico C et al (2009) Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice. Vaccine 27:5069ā5076
Lim J etĀ al (2010) Formation of au/Pd alloy nanoparticles on TMV. J Nanomater 2010:620505. https://doi.org/10.1155/2010/620505
Liu J etĀ al (2016) Virus like particle-based vaccines against emerging infectious disease viruses. Virol Sin 31(4):279ā287. https://doi.org/10.1007/s12250-016-3756-y
Lomonossoff GP, Commandeur U (2015) Production of hybrid chimeric PVX Particles Using a combination of TMV and PVX-Based expression Vectors. Front Bioeng Biotechnol 3(November):1ā12. https://doi.org/10.3389/fbioe.2015.00189
Loo L et al (2007) Encapsidation of nanoparticles by red clover necrotic mosaic virus. J Am Chem Soc 129(36):11111ā11117
Loo L et al (2008) Infusion of dye molecules into red clover necrotic mosaic virus. Chem Commun 1:88ā90
Luckanagul J etĀ al (2012) Porous alginate hydrogel functionalized with virus as three-dimensional scaffolds for bone differentiation. Biomacromolecules 13(12):3949ā3958
Lucon J etĀ al (2012) Polymerization with high-density cargo loading. Nat Chem 4:781ā788. https://doi.org/10.1038/NCHEM.1442.
Luo D, Carter KA, Lovell JF (2016) Nanomedical engineering : shaping future nanomedicines. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7(2):169ā188. https://doi.org/10.1002/wnan.1315.Nanomedical
Mallajosyula JK et al (2014) Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge. Hum Vaccin Immunother 10:586ā595
Marsian J, Lomonossoff GP (2016) Molecular pharmingāVLPs made in plants. Curr Opin Biotechnol 37:201ā206
Marusic C et al (2001) Chimeric Plant Virus particles as immunogens for inducing murine and human immune responses against Human Immunodeficiency Virus Type 1. 75(18):8434ā8439. https://doi.org/10.1128/JVI.75.18.8434
Masarapu H et al (2017) Physalis mottle virus-like particles as Nanocarriers for imaging reagents and drugs. Biomacromolecules 18(12):4141ā4153
Massa S et al (2008) Antitumor activity of DNA vaccines based on the human papillomavirus-16 E7 protein genetically fused to a plant virus coat protein. Hum Gene Ther 19:354ā364
Mathieu C et al (2013) Induction of innate immunity in lungs with Pneumoniae, virus-like nanoparticles leads to protection against influenza and Streptococcus challenge.ā, Nanomedicine. Nanotechnology 9:839ā848
MC G, Kallinteri P (2006) Nanomedicines and nanotoxicology: some physiological principles. Occup Med 56(5):307ā311
McCormick A, Corbo T, Wykoff-Clary S, Palmer K et al (2006a) Chemical conjugate tmv-peptide bivalent fusion vaccines improve cellular immunity and tumor protection. Bioconjug Chem 17:1330ā1338
McCormick A, Corbo T, Wykoff-Clary S, Nguyen L et al (2006b) Tmv-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models. Vaccine 24:6414ā6423
McInerney TL et al (1999) Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide. Vaccine 17:1359ā1368
Miermont A et al (2008) Cowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines. Chemistry 14(16):4939ā4947
Miller RA, Presley AD, Francis MB (2007) Self-assembling light-harvesting systems from synthetically modified tobacco mosaic virus coat proteins. J Am Chem Soc 129(11):3104ā3109
Moghadam MM, Motalleb G, Fakheri A (2015) Nanoparticles and plant biotechnology. Research in Biotechnology 6(5):1ā15
Molinar P, Peralta A, Taboga O (2008) Production of rotavirus-like particles in Spodoptera frugiperda larvae. Method J Virol 147(2):364ā367
Morikawa Y, Goto T, Momose F (2004) Human immunodeficiency virus type 1 gag assembly through assembly intermediates. J Biol Chem 279:31964ā31972
Nam K et al (2006) Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes. Science 312(5775):885ā888
Nuzzaci M et al (2007) Cucumber mosaic virus as a presentation system for a double hepatitis C virus-derived epitope. Arch Virol 152:915ā928
Palmer KE et al (2006) Protection of rabbits against CUTANEOUS papillomavirus infection using recombinant tobacco mosaic virus containing l2 capsid epitopes. Vaccine 24:5516ā5525
Pan Y et al (2017) A Therapeutic Peptide Vaccine Against PCSK9ā, Scientific Reports. Springer US, 7, p 12534. https://doi.org/10.1038/s41598-017-13069-w
Patel R et al (2018) Radiation therapy combined with Cowpea Mosaic Virus nanoparticle in Situ Vaccination initiates immune-mediated tumor regression. 6ā11. https://doi.org/10.1021/acsomega.8b00227.
Patterson D, Schwarz B, Western B, Terra M, Krugler P et al (2008) Engineering virus like particles towards directing immunologic responses. Faculty Posters. Book 9. http://hdl.handle.net/10950/362
Pettersen EF et al (2004) UCSF chimeraāa visualization system for exploratory research and analysis. J Comput Chem 25:1605ā1612. https://doi.org/10.1002/jcc.20084
Phelps JP, Dang N, Rasochova L (2008) Inactivation and purification of cowpea mosaic virus-like particles displaying peptide antigens from Bacillus anthracis. J Virol Methods 141(2):146ā153
Piazzolla G et al (2005) Immunogenic properties of a chimeric plant virus expressing a hepatitis C virus (HCV)-derived epitope: new prospects for an HCV vaccine. J Clin Immunol 25(2):142ā152
Pickett G, Peabody D (1993) Encapsidation of heterologous RNAs by bacteriophage MS2 coat protein. Nucleic Acids Res 21(19):4621ā4626
Pillet S et al (2018) Humoral and cell-mediated immune responses to H5N1 plant- made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial, npj Vaccines. Springer US, 3, p. 3. doi:https://doi.org/10.1038/s41541-017-0043-3.
Pires DP et al (2016) Genetically Engineered Phages: a review of advances over the last. 80(3):523ā543. https://doi.org/10.1128/MMBR.00069-15.Address
Pitek AS et al (2018) Elongated plant virus-based nanoparticles for enhanced delivery of thrombolytic therapies. Mol Pharmacol 14(11):3815ā3823. https://doi.org/10.1021/acs.molpharmaceut.7b00559.Model.
Pokorski JK, Steinmetz NF (2011) The art of engineering viral nanoparticles. Mol Pharmacol 8(1):29ā43. https://doi.org/10.1021/mp100225y.The.
Pokorski JK, Breitenkamp K, Finn MG (2012) Functional virus-based polymer-protein nanoparticles by atom transfer radical polymerization. J Am Chem Soc 133(24):9242ā9245. https://doi.org/10.1021/ja203286n.Functional
Ponterio E et al (2013) Pattern of activation of human antigen presenting cells by genotype GII. 4 norovirus virus-like particles. J Transl Med 11:8ā10
Prasuhn DJ et al (2007) Viral MRI contrast agents: coordination of Gd by native virions and attachment of Gd complexes by azide-alkyne cycloaddition. Chem Commun (12):1269ā1271
Ren Y, Wong S, Lim L (2007) Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. Bioconjug Chem 18:836ā843
Rohovie MJ, Nagasawa M, Swartz JR (2017) Virus-like particles: next-generation nanoparticles for targeted therapeutic delivery. (August 2016), pp 43ā57. https://doi.org/10.1002/btm2.10049
Rose R et al (1998) Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies. J Virol 72(7):6151ā6154
Sangita V et al (2004) T=1 capsid structures of Sesbania mosaic virus coat protein mutants : determinants of T=3 and T=1 capsid assembly. J Mol Biol 342:987ā999. https://doi.org/10.1016/j.jmb.2004.07.003
Sangita V, Lokesh GL et al (2005a) Research papers structural studies on recombinant T = 3 capsids of Sesbania mosaic virus coat protein mutants research papers. Acta Crystallogr D Biol Crystallogr D61:1402ā1405. https://doi.org/10.1107/S0907444905024029
Sangita V, Satheshkumar PS et al (2005b) Research papers structure of a mutant T = 1 capsid of Sesbania mosaic virus: role of water molecules in capsid architecture and integrity research papers. Acta Crystallogr D Biol Crystallogr D61:1406ā1412. https://doi.org/10.1107/S0907444905024030
Savard C et al (2011) Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles. PLoS One 6:E21522
Schlick T et al (2005) Dual-surface modification of the tobacco mosaic virus. J Am Chem Soc 127(11):3718ā3723
Schneemann A et al (1993) Use of recombinant Baculoviruses in synthesis of morphologically distinct Viruslike particles of flock house virus, a Nodavirus. J Virol 67(5):2756ā2763
Schoonen L et al (2018) Modular, bioorthogonal strategy for the controlled loading of cargo into a protein Nanocage. Bioconjug Chem 29:1186ā1193. https://doi.org/10.1021/acs.bioconjchem.7b00815
Shanks M, Lomonossoff GP (2000) Co-expression of the capsid proteins of cowpea mosaic virus in insect cells leads to the formation of virus-like particles. J Gen Virol 81:3093ā3097
Shenton W et al (1999) Inorganicāorganic nanotube composites from template mineralization of tobacco mosaic virus. Adv Mater 11(3):253ā256
Shukla S, Steinmetz NF (2016) Minireview emerging nanotechnologies for cancer immunotherapy. Exp Biol Med 241:1116ā1126. https://doi.org/10.1177/1535370216647123
Shukla S et al (2014a) Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle potato virus X. Mol Pharmacol 10(1):33ā42. https://doi.org/10.1021/mp300240m.Increased.
Shukla S, Dickmeis C et al (2014b) Molecular farming of fluorescent virus-based nanoparticles for optical imaging in plants, human cells and mouse models. Biomater Sci 2:784ā797
Shukla S, Wen A et al (2014c) Presentation of HER2 epitopes using a filamentous plant virus-based vaccination platform. J Mater Chem B 2:6249ā6258
Shukla S et al (2017) Plant viral nanoparticles-based HER2 vaccine: immune response influenced by differential transport, localization and cellular interactions of particulate carriers. Biomaterials 121:15ā27
Singh P et al (2010) Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo. J Control Release 120(1ā2):41ā50. https://doi.org/10.1016/j.jconrel.2007.04.003.Bio-distribution
Skwarczynski M, Toth I (2016) Chemical science peptide-based synthetic vaccines. Chem Sci 7:842ā854. https://doi.org/10.1039/C5SC03892H
Smith TJ et al (2000) The structure of cucumber mosaic virus and comparison to cowpea Chlorotic mottle virus. Am Soc Microbiol 74(16):7578ā7586
Smith MT et al (2013) Enhanced protein stability through minimally invasive, direct, covalent, and site-specific immobilization. Biotechnol Prog 29(1):247ā254. https://doi.org/10.1002/btpr.1671
Souli JC et al (1991) Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens. Vaccine 9(8):545ā548
Staczek J etĀ al (2000) Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa. Vaccine 18(21):2266ā2274
Steinmetz NF, Manchester M (2011) Viral nanoparticles. Pan Stanford Publishing Pte. Ltd., Singapore
Steinmetz NF et al (2010) Buckyballs meet viral nanoparticlesĀ ā candidates for biomedicine. J Am Chem Soc 131(47):17093ā17095. https://doi.org/10.1021/ja902293w.Buckyballs
Storni T et al (2002) Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles. J Immunol 168:2880ā2886
Storni T et al (2018) Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J Immunol 172:1777ā1785. https://doi.org/10.4049/jimmunol.172.3.1777
Strable E et al (2009) Unnatural amino acid incorporation into virus-like particles Erica. Bioconjug Chem 19(4):866ā875. https://doi.org/10.1021/bc700390r.Unnatural.
Takahashi RU et al (2008) Presentation of functional foreign peptides on the surface of SV40 virus-like particles. J Biotechnol 135:385ā392
Tinazzi E et al (2015) Plant-derived chimeric virus particles for the diagnosis of primary Sjƶgren syndrome. Front Plant Sci 6:1080. https://doi.org/10.3389/fpls.2015.01080
Tumban E et al (2011) A Pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2. PLoS One 6(8):e23310
Tyulkina LG et al (2011) New viral vector for Superproduction of epitopes of vaccine proteins in plants. Acta Nat 3(11):4ā6
Uchida M et al (2012) Site-directed coordination chemistry with P22 virus-like particles. Langmuir 28(4):1998ā2006
Uhde-Holzem K et al (2010) Immunogenic properties of chimeric potato virus X particles displaying the hepatitis C virus hypervariable region I peptide R9. J Virol Methods 166:12ā20
Vaculik P et al (2015) New positions for peptide presentation in potato virus X capsid protein. Open Life Sciences 10:133ā141. https://doi.org/10.1515/biol-2015-0019
van Eldijk MB et al (2013) Designing two self-assembly mechanisms into one viral capsid protein. J Am Chem Soc 134(16):18506ā18509. https://doi.org/10.1021/ja308132z.Designing
Van Hest JCM, Cornelissen JJLM, Koay MST (2014) Using viruses as nanomedicines. Br J Pharmacol 171:4001ā4009. https://doi.org/10.1111/bph.12662
Venkataraman S et al (2009) Structure of Seneca Valley Virus-001, an oncolytic picornavirus representing a new genus. Structure 16(10):1555ā1561. https://doi.org/10.1016/j.str.2008.07.013.Structure
Venkataraman S, Savithri HS, Murthy MRN (2018) Structural aspects of plant viruses. In: Plant viruses diversity, interaction and management. CRC Press, Boca Raton, pp 3ā26
Venter PA et al (2011) Multivalent display of proteins on viral nanoparticles using molecular recognition and chemical ligation strategies. Biomacromolecules 12:2293ā2301
Vitiello C, Adhya MC (2005) An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold. Virus Res 114(1ā2):101ā103
Wang J, Roden R (2013) Virus-like particles for the prevention of human papillomavirus-associated malignancies. Exp Rev Vaccin 12(2):129ā141
Wang X et al (2012) Biomineralization-based virus Shell-engineering: towards neutralization biomineralization-based virus Shell-engineering: towards neutralization escape and tropism expansion. Adv Healthc Mater 1(July):443ā449. https://doi.org/10.1002/adhm.201200034.
Wen AM, Steinmetz NF (2016) Design of virus-based nanomaterials for medicine, biotechnology, and energy. Chem Soc Rev 45(15):4074ā4126. https://doi.org/10.1039/C5CS00287G
Wen AM et al (2013) Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine. J Biol Phys 39:301ā325. https://doi.org/10.1007/s10867-013-9314-z
Wen AM et al (2015) Tropism of CPMV to professional antigen presenting cells enables a platform to eliminate chronic infections. ACS Biomater Sci Eng 1(11):1050ā1054
Wena AM, Steinmetza NF (2016) Design of virus-based nanomaterials for medicine, biotechnology, and energy. Chem Soc Rev:1ā140
Whaley SR et al (2000) Selection of peptides with semiconductor binding specificity for directed nanocrystal assembly. Nature 405(6787):665ā668
Wu Z et al (2013) Development of viral nanoparticles for efficient intracellular delivery. Nanoscale 4(11):3567ā3576. https://doi.org/10.1039/c2nr30366c.
Yaddanapudi K, Mitchell R, Eaton J (2013) Cancer vaccines: looking to the future. Oncoimmunology 2:e23403
Yan D et al (2015) The application of virus-like particles as vaccines and biological vehicles. Appl Microbiol Biotechnol 99:10415ā10432. https://doi.org/10.1007/s00253-015-7000-8
Yang CD et al (2007) Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes. BMC Biotechnol. https://doi.org/10.1186/1472-6750-7-62
Yin Z, Nguyen HG, Chowdhury S, Bentley P, Bruckman MA et al (2012) Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens. Bioconjug Chem 23:1694ā1703
Yoo SY, Merzlyak A, Lee S (2014) Synthetic phage for tissue regeneration. Mediators of Inflammatio. Hindawi Publishing Corporation, 2014. https://doi.org/10.1155/2014/192790
Yusibov V, Rabindran S (2008) Recent progress in the development of plantĀ ā derived vaccines. Expert Rev Vaccin 7:1173ā1183
Yusibov V et al (1997) Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc Natl Acad Sci 94:5784ā5788
Yusibov V et al (2005) Peptide-based candidate vaccine against respiratory syncytial virus. Vaccine 23:2261ā2265
Zeng Q et al (2013) Cucumber mosaic virus as drug delivery vehicle for doxorubicin. Biomaterials 34(19):4632ā4642
Zhang W et al (2017) Encapsulation of inorganic nanomaterials inside virus-based nanoparticles for bioimaging. Nano 1(4):358ā368. https://doi.org/10.7150/ntno.21384
Zilker C et al (2017) Nanoparticle-based B-cell targeting vaccines: tailoring of humoral immune responses by functionalization with different TLR-ligands. Nanomedicine 13(1):173ā182
Acknowledgement
SV acknowledges financial support from SERB, DST (ECR/2016/000242).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Venkataraman, S., Reddy, V.S., Khurana, S.M.P. (2020). Biomedical Applications of Viral Nanoparticles in Vaccine Therapy. In: Saxena, S., Khurana, S. (eds) NanoBioMedicine. Springer, Singapore. https://doi.org/10.1007/978-981-32-9898-9_9
Download citation
DOI: https://doi.org/10.1007/978-981-32-9898-9_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9897-2
Online ISBN: 978-981-32-9898-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)